Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
An announcement from Smith & Nephew Snats ( (SNN) ) is now available.
Smith+Nephew announced it will host Capital Markets Days in London and New York on December 8 and 11, 2025, respectively. These events will introduce the company’s new strategy following its 12-Point Plan and provide insights into its innovative portfolio aimed at driving future growth. Led by CEO Deepak Nath, these sessions are significant for institutional investors and analysts, offering a detailed view of the company’s strategic direction and growth potential.
The most recent analyst rating on (SNN) stock is a Buy with a $40.00 price target. To see the full list of analyst forecasts on Smith & Nephew Snats stock, see the SNN Stock Forecast page.
Spark’s Take on SNN Stock
According to Spark, TipRanks’ AI Analyst, SNN is a Outperform.
Smith & Nephew Snats shows strong financial performance with robust revenue and profit growth, which is the most significant factor in its stock score. The earnings call provided positive insights into future growth, despite some challenges in emerging markets and potential tariff impacts. The technical analysis indicates weak momentum, and the stock’s valuation is relatively high, which slightly offsets the overall positive outlook.
To see Spark’s full report on SNN stock, click here.
More about Smith & Nephew Snats
Smith+Nephew is a global medical technology company focused on the repair, regeneration, and replacement of soft and hard tissue. With a mission to enhance people’s lives through technology, it operates in over 100 countries and generated $5.8 billion in sales in 2024. The company is a constituent of the FTSE100 and operates across three business units: Orthopaedics, Sports Medicine & ENT, and Advanced Wound Management.
Average Trading Volume: 879,276
Technical Sentiment Signal: Buy
Current Market Cap: $15.26B
For a thorough assessment of SNN stock, go to TipRanks’ Stock Analysis page.